Literature DB >> 9649130

Telomerase activity in benign and malignant human thyroid tissues.

A J Cheng1, J D Lin, T Chang, T C Wang.   

Abstract

Telomerase is a specialized ribonucleoprotein polymerase that directs the synthesis of telomerase repeats at chromosome ends. Accumulating evidence has indicated that telomerase is stringently repressed in normal human somatic tissues but reactivated in cancers and immortal cells, suggesting that activation of telomerase activity plays a role in carcinogenesis and immortalization. In this work, the status of telomerase activity during the development of human thyroid cancer was determined using telomeric repeat amplification protocol (TRAP) in 14 nodular hyperplasia, 14 adenomas, 23 papillary carcinomas and 11 follicular carcinomas. Positive telomerase activity was detected in 2 of 14 nodular hyperplasias (14%), 4 of 14 adenomas (29%), 12 of 23 papillary carcinomas (52%) and 10 of 11 follicular carcinomas (91%). The cancers that are negative for telomerase activity are mostly in early stage (stage I or II). These results suggest that telomerase reactivation plays a role during the development of thyroid cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649130      PMCID: PMC2150404          DOI: 10.1038/bjc.1998.363

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  25 in total

1.  Telomerase activity in benign and malignant thyroid tumors.

Authors:  B R Haugen; S Nawaz; N Markham; T Hashizumi; A L Shroyer; B Werness; K R Shroyer
Journal:  Thyroid       Date:  1997-06       Impact factor: 6.568

2.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

Review 3.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

4.  Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.

Authors:  C B Umbricht; M Saji; W H Westra; R Udelsman; M A Zeiger; S Sukumar
Journal:  Cancer Res       Date:  1997-06-01       Impact factor: 12.701

5.  Activated ras oncogenes in human thyroid cancers.

Authors:  N R Lemoine; E S Mayall; F S Wyllie; C J Farr; D Hughes; R A Padua; V Thurston; E D Williams; D Wynford-Thomas
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

6.  The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy.

Authors:  J B Vander; E A Gaston; T R Dawber
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

Review 7.  Telomerase, cell immortality, and cancer.

Authors:  C B Harley; N W Kim; K R Prowse; S L Weinrich; K S Hirsch; M D West; S Bacchetti; H W Hirte; C M Counter; C W Greider
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1994

8.  Clinical presentations and treatment for 74 occult thyroid carcinoma. Comparison with nonoccult thyroid carcinoma in Taiwan.

Authors:  J D Lin; T C Chao; H F Weng; H S Huang; Y S Ho
Journal:  Am J Clin Oncol       Date:  1996-10       Impact factor: 2.339

9.  Telomerase activity in vivo in human malignant hematopoietic cells.

Authors:  P Nilsson; C Mehle; K Remes; G Roos
Journal:  Oncogene       Date:  1994-10       Impact factor: 9.867

10.  p53 gene mutation in thyroid carcinoma.

Authors:  Y S Ho; S C Tseng; T Y Chin; L L Hsieh; J D Lin
Journal:  Cancer Lett       Date:  1996-05-15       Impact factor: 8.679

View more
  10 in total

Review 1.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

2.  Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.

Authors:  A M Straight; A Patel; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 3.  Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.

Authors:  M D Ringel
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

4.  Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.

Authors:  Yongchun Wang; Jeanne Kowalski; Hua-Ling Tsai; Radharani Marik; Nijaguna Prasad; Helina Somervell; Pang-Kuo Lo; Lauren E Sangenario; Lars Dyrskjot; Torben F Orntoft; William H Westra; Alan K Meeker; James R Eshleman; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

5.  Telomeres and thyroid cancer.

Authors:  Marco Capezzone; Stefania Marchisotta; Silvia Cantara; Furio Pacini
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

6.  The Clinicopathologic Significance of Unilateral Adrenal Cortical Hyperplasia: Report of an Unusual Case and a Review of the Literature.

Authors:  King-Yin Lam; Chung-Yau Lo
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

7.  Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease.

Authors:  Leticia Bornstein-Quevedo; M L García-Hernández; Ignacio Camacho-Arroyo; Miguel F Herrera; Arturo Angeles Angeles; Ofelia González Treviño; Armando Gamboa-Domínguez
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Authors:  Paula Soares; Jorge Lima; Ana Preto; Patricia Castro; João Vinagre; Ricardo Celestino; Joana P Couto; Hugo Prazeres; Catarina Eloy; Valdemar Máximo; M Sobrinho-Simões
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

9.  Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues.

Authors:  J T Chang; C T Liao; S M Jung; T C Wang; L C See; A J Cheng
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

10.  Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation.

Authors:  Nighat Noureen; Shaofang Wu; Yingli Lv; Juechen Yang; W K Alfred Yung; Jonathan Gelfond; Xiaojing Wang; Dimpy Koul; Andrew Ludlow; Siyuan Zheng
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.